Marketwire
SALT LAKE CITY, UT--(Marketwire - May 26, 2009) - Paradigm Medical Industries, Inc.
(OTCBB: PDMI) announced today that the Company plans to begin the important
process of upgrading its CPT code (0189T) for its Blood Flow Analyzer from
the American Medical Association from an investigational level (Class III)
to one that will enable public and private medical centers to be reimbursed
by their regional medical insurance companies for testing patients using
the Blood Flow Analyzer. The Blood Flow Analyzer is used to detect glaucoma
and aid in managing the disease.
Current Procedural Terminology (CPT) coding is a standard, universal code
that is applied to medical procedures and services for the purpose of
patient records. CPT is to provide a uniform language that accurately
describes medical, surgical, and diagnostic services, and thereby serves as
an effective means for reliable nationwide communication among physicians,
and other healthcare providers, patients and third parties. Receiving a
reimbursable CPT Code will be an important step towards the Blood Flow
Analyzer's acceptance as a standard diagnostic instrument in early
detection of glaucoma in patients.
"We are confident that by taking the next important clinical steps to
complete the process of upgrading this CPT code to a reimbursable level,
both public and private payers will be encouraged to reimburse physicians
for utilizing the Blood Flow Analyzer," said Paradigm Medical President
Stephen Davis. "Moving the Blood Flow Analyzer from an investigational
level to an acceptable diagnostic procedure will benefit patients and
physicians alike by offering earlier glaucoma diagnosis and treatment."
About Paradigm Medical Industries, Inc.
Headquartered in Salt Lake City, UT, Paradigm Medical Industries, Inc. is a
medical device company that develops, manufactures and distributes cutting
edge, new innovative products in the diagnostic ultrasound and early
glaucoma detection markets. Paradigm has the only patented technology
utilizing photon laser for cataract removal. The Company is poised to
capture a niche market within the Glaucoma and ultrasound microscopy
fields. Paradigm Medical Industries markets its products to
ophthalmologists, optometrists, universities, and clinics throughout the
United States, as well as internationally.
For more information, please visit: www.paradigm-medical.com
This press release contains statements that, if not verifiable historic
fact, may be viewed as forward-looking statements that could predict future
events and outcomes with respect to Paradigm and its business. The
predictions embodied in these statements will involve risk and
uncertainties and, accordingly, actual results may differ significantly
from the results discussed or implied in such forward-looking statements.